MedTrace Logo

Remote Blood Pressure Management Clinical Application Research

NCT04690478 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1050

Last updated 2022-02-17

No results posted yet for this study

Summary

Recruit patients with essential hypertension and randomly divide them into three groups. For 24 months, observe the patient's blood pressure level and blood pressure compliance rate,Risk assessment, etc.

Conditions

Interventions

DEVICE

Electronic remote blood pressure monitor

Remote blood pressure management group through remote blood pressure management the platform realizes functions such as automatic upload of patient measurement data, intelligent analysis, and early warning reminders

DEVICE

Ordinary household electronic sphygmomanometer

One group is distributed a set of ordinary household electronic sphygmomanometer, and the blood pressure is recorded by themselves at home following routine community office follow-up

DEVICE

Office electronic sphygmomanometer

One group follows routine community office follow-up and uses office electronic sphygmomanometer to measure blood pressure

Sponsors & Collaborators

  • The Affiliated Hospital of Qingdao University

    lead OTHER

Principal Investigators

  • Yu haichu, master · Affiliated Cardiovascular Hospital of Qingdao University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2023-03-31
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04690478 on ClinicalTrials.gov